BackgroundCheck.run
Search For

Sandra L Quinlan, 578 Daden Ln, Simsbury, CT 06092

Known as:
Sandra Leigh Quinlan Sandra L Kuhr Sandra L Quinea Quinlan Sandra Sandra N
Related to:
Joanna E Sutherland 59

Sandra Quinlan Phones & Addresses

8 Daden Ln, West Simsbury, CT 06092    860-2170096   

151 Quinlan Dr, Barre, VT 05641    802-4768796   

Port Charlotte, FL   

Manlius, NY   

Baldwinsville, NY   

Plattsburgh, NY   

Mystic, CT   

Get Report
Control this profile

Mentions for Sandra L Quinlan

Sandra Quinlan resumes & CV records

Resumes

Sandra Quinlan Photo 26

Science Faculty

Location:
West Simsbury, CT
Industry:
Education Management
Work:
The Ethel Walker School Incorporated
Science Faculty Bristol-Myers Squibb 2003 - 2005
Research Scientist American Advanced Organics 1998 - 2000
Research Chemist Bristol-Myers Squibb 1992 - 1998
Associate Research Scientist
Education:
State University of New York College at Oswego
Bachelors, Biology, Chemistry Syracuse University
Masters, Chemistry
Sandra Quinlan Photo 27

Sandra Quinlan

Sandra Quinlan Photo 28

Sandra Quinlan

Sandra Quinlan Photo 29

Sandra Quinlan

Sandra Quinlan Photo 30

Sandra Quinlan

Location:
United States
Sandra Quinlan Photo 31

Sandra Quinlan

Publications & IP owners

Us Patents

Hmg-Coa Reductase Inhibitors And Method

US Patent:
2005017, Aug 4, 2005
Filed:
Nov 15, 2004
Appl. No.:
10/989138
Inventors:
Stephen O'Connor - Lambertville NJ, US
Jeffrey Robl - Newtown PA, US
Saleem Ahmad - Wall NJ, US
Sharon Bisaha - Lambertville NJ, US
Natesan Murugesan - Princeton Juction NJ, US
Khehyong Ngu - Pennington NJ, US
Yan Shi - Flourtown PA, US
Philip Stein - Pennington NJ, US
Nachimuthu Soundararajan - Kendall Park NJ, US
Kenneth Natalie - Flemington NJ, US
Laxma Kolla - Plainsboro NJ, US
Justin Sausker - Middletown CT, US
Sandra Quinlan - West Simsbury CT, US
Junying Fan - Monmouth Junction NJ, US
Dejah Petsch - Ashford CT, US
Zhenrong Guo - East Brunswick NJ, US
International Classification:
A61K031/4745
C07D471/02
US Classification:
514300000, 546122000
Abstract:
Compounds are provided having the following structure and pharmaceutically acceptable salts thereof, wherein R, R, R, R, U, V, W, Y, and n are as defined above, which compounds are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol, and treating hyperlipidemia, dyslipidemia, hypercholesterolemia, hypertriglyceridemia and atherosclerosis as well as Alzheimer's disease and osteoporosis and may be employed as hormone replacement therapy. A method for treating the above diseases employing the above compounds is also provided.

Preparation Of 2',3'-Didehydro-3'-Deoxythymidine From 5-Methyluridine

US Patent:
5672698, Sep 30, 1997
Filed:
Sep 23, 1994
Appl. No.:
8/309637
Inventors:
Derron Ray Stark - Syracuse NY
Stephen Richard Baker - Cicero NY
Sandra L. Quinlan - Manlius NY
Assignee:
Bristol-Myers Squibb Co. - New York NY
International Classification:
C07H 100
C07H 106
C07H 19073
US Classification:
536 553
Abstract:
An economical process, amenable to large-scale production, is disclosed for the preparation of 2',3'-didehydro-3'-deoxythymidine (d4T) from 5-methyluridine. The process employs a novel, 5'-,acyl-2'. alpha. -halo-3'. alpha. -alkanesulfonylthymidine intermediate as well as a highly efficient and practical deprotection, isolation and purification procedure for the d4T product.

Process For Preparing Azt

US Patent:
5466787, Nov 14, 1995
Filed:
Nov 15, 1993
Appl. No.:
8/152803
Inventors:
Sandra L. Quinlan - Manlius NY
Assignee:
Bristol-Myers Squibb Company - DE
International Classification:
C07H 100
C07H 19173
US Classification:
536 553
Abstract:
A process for preparing AZT and comprising the steps of: a) reacting a 2'-halo-5'-protected pyrimidinyl 2'-deoxyribonucleoside having a 3'-sulfonyl group with tributyl tin hydride and catalytic amount of azobisisobutyronitrile in an ether, ester, or ketone solvent to yield a dehalogenated pyrimidinyl 2'-deoxyribonucleoside; followed by b) reacting said dehalogentated pyrimidinyl 2'-deoxynucleoside formed in step (a) with a base, a lithium salt, and an azide salt to yield a 5'-protected pyrimidinyl 3'-dideoxy-3'-azido-ribonucleoside; and c) deprotecting the nucleoside derivative of step (b) to yield 3'-dideoxy-3'-azidothymidine.

Preparation Of D4T From 5-Methyluridine

US Patent:
5608049, Mar 4, 1997
Filed:
Mar 10, 1995
Appl. No.:
8/402283
Inventors:
Richard H. Spector - Fayetteville NY
Sandra L. Quinlan - Manlius NY
Assignee:
Bristol-Myers Squibb Company - New York NY
International Classification:
C07H 19073
US Classification:
536 282
Abstract:
The present invention concerns an improved process of making d4T from 5-MU. Another aspect of the invention relates to useful intermediates produced during the process.

Possible Relatives

Cynthia L Quinlan  David J Quinlan  Dawn M Quinlan  Deanna R Quinlan  Dana K Quinlan  Debra J Quinlan  Daniel J Quinlan  Sandra Last  Sandra J Johnson  Sandra L Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.